| Gwyne Alden, RN | |
|
66 Pomfret Rd, Narragansett, RI 02882-1646 | |
| (401) 782-2434 | |
| Not Available |
| Full Name | Gwyne Alden |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Pediatrics |
| Location | 66 Pomfret Rd, Narragansett, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386233765 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WP0200X | Registered Nurse - Pediatrics | RN38295 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Gwyne Alden, RN 66 Pomfret Rd, Narragansett, RI 02882-1646 Ph: (401) 782-2434 | Gwyne Alden, RN 66 Pomfret Rd, Narragansett, RI 02882-1646 Ph: (401) 782-2434 |
News Archive
Elsevier, a world-leading provider of scientific, technical and medical information products and services, and Kitware, a worldwide leader in developing advanced visualization technologies, today announced that Elsevier journals offer the opportunity to upload 3D datasets when submitting a paper for publication. This way, once published, readers can interactively explore 3D datasets next to the online article on ScienceDirect.
For people diagnosed with depression, it's important that they adhere to their medication regimen so that they avoid recurrent episodes. But because of Medicare's Part D coverage gap, financially burdened seniors might not take their prescriptions as recommended. This study looked at Medicare beneficiaries diagnosed with depression in 2007.
Acetylon Pharmaceuticals today announced the initiation of patient treatments in a three-part Phase 1-2a clinical trial of ACY-1215, an oral Class II histone deacetylase (HDAC) inhibitor, in adults with relapsed and relapsed/refractory multiple myeloma.
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing ten new Collaborative Research Centers (CRCs) to further support top-level research in Germany.
BioLineRx, a biopharmaceutical development company, announced today that it intends to conduct an interim analysis of the Phase II/III CLARITY trial of BL-1020, a first in class, orally available, GABA-enhanced antipsychotic for the treatment of schizophrenia.
› Verified 8 days ago
Michelle Lyn Reca, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 360 Kingstown Rd Unit 101, Narragansett, RI 02882 Phone: 401-789-6492 Fax: 401-783-9448 | |
Lauren Sequin, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Foddering Farm Rd, Narragansett, RI 02882 Phone: 401-323-7272 | |
Mrs. Ashley Sousa, RN IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 11 Juniper Trl, Narragansett, RI 02882 Phone: 401-487-8619 | |
Mr. Scott Spencer Maynard, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 24 Overlook Rd, Narragansett, RI 02882 Phone: 401-788-9584 | |
Tanya Sequin, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 240 Foddering Farm Rd, Narragansett, RI 02882 Phone: 401-743-1468 | |
Michaela Cottam, FNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3 Morgan Dr, Narragansett, RI 02882 Phone: 401-447-5314 |